Epidemiology and comorbidity of arterial hypertension and gallstone disease
https://doi.org/10.15829/1560-4071-2019-6-143-148
Abstract
The review presents current data on the Arterial Hypertension (AH) and Gallstone Disease (GSD) prevalence. The heterogeneity of the relationship between cardiovascular diseases, AH and GSD was shown. According to our data, in Novosibirsk, in the population sample of women 25-64 years with/without GSD (n=870) prevalence of AH (criteria blood pressure (BP) >160/95, WHO MONICA project, 1994-1995) was 41,6% and 31,3%, p<0,05. In this female population as a whole (n=1663) prevalence of AH was 30,8%. But with the criteria of BP >140/90, the corresponding indicators of prevalence of AH were similar: 55,4%, 47,1% and 49,0%. The evidence of the association between the GSD and the carotid arteries intima-media thickness, as atherosclerosis marker, is presented, and the main mechanisms of development of AH in GSD are highlighted. Gastroenterological symptoms, BP, blood lipids, quality of life were compared, which were worse in comorbid patients with GSD and AH than in GSD or AH. The expediency of an active approach to the detection of GSD and AH in terms of their contribution to cardiovascular prognosis is shown.
Supporting agencies: “Epidemiological monitoring of the state of public health and the study of molecular genetic and biological mechanisms for the development of common therapeutic diseases in Siberia to improve approaches to their diagnostics, prevention and treatment” state task № 0324-2018-0001, Reg. № AAAA-A17-17112850280-2
About the Authors
I. N. Grigorieva
Scientific Research Institute of Therapy and Preventive Medicine — a branch of Federal Research Center Institute of Cytology and Genetics; Novosibirsk National Research State University
Russian Federation
Novosibirsk.
Competing Interests: Nothing to declare
Russian Federation
Novosibirsk.
Competing Interests: Nothing to declare
Yu. I. Ragino
Scientific Research Institute of Therapy and Preventive Medicine — a branch of Federal Research Center Institute of Cytology and Genetics
Russian Federation
Novosibirsk.
Competing Interests: Nothing to declare
Russian Federation
Novosibirsk.
Competing Interests: Nothing to declare
T. I. Romanova
Scientific Research Institute of Therapy and Preventive Medicine — a branch of Federal Research Center Institute of Cytology and Genetics
Russian Federation
Novosibirsk.
Competing Interests: Nothing to declare
Russian Federation
Novosibirsk.
Competing Interests: Nothing to declare
References
1. Williams B, Mancia G, Spiering W, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2018;36 (12):2284-309. doi:10.1097/HJH.0000000000001961.
2. Mills KT, Bundy JD, Kelly TN, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134 (6):441-50. doi:10.1161/CIRCULATIONAHA.115.018912.
3. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310 (9):959-68. doi:10.1001/jama.2013.184182.
4. Fairfield CJ, Wigmore SJ, Harrison EM. Gallstone Disease and the Risk of Cardiovascular Disease Sci Rep. 2019;9:5830. doi:10.1038/s41598-019-42327-2.
5. Upala S, Sanguankeo A, Jaruvongvanich V. Gallstone Disease and the Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Observational Studies. Scand J Surg. 2017;106 (1):21-7. doi:10.1177/1457496916650998.
6. Zheng Y, Xu M, Heianza Y, et al. Gallstone disease and increased risk of mortality: Two large prospective studies in US men and women. J Gastroenterol Hepatol. 2018;33 (11):1925-31. doi:10.1111/jgh.14264.
7. Shabanzadeh DM, Skaaby T, Sorensen LT, et al. Screen-detected gallstone disease and cardiovascular disease. Eur J Epidemiol. 2017;32 (6):501-10. doi:10.1007/s10654-017-0263-x.
8. Olaiya MT, Chiou HY, Jeng JS, et al. Significantly increased risk of cardiovascular disease among patients with gallstone disease: a population-based cohort study. PLoS One. 2013;8 (10): e76448. doi:10.1371/journal.pone.0076448.
9. Fan LL, Chen BH, Dai ZJ. The relation between gallstone disease and cardiovascular disease. Sci. Reports. 2017;7:15104. doi:10.1038/s41598-017-15430-5.
10. Zhao SF, Wang AM, Yu XJ, et al. Association between gallstone and cardio-cerebrovascular disease: Systematic review and meta-analysis. Exp Ther Med. 2019;17 (4):3092-100. doi:10.3892/etm.2019.7291.
11. Mendez-Sanchez N, Bahena-Aponte J, Chavez-Tapia N, et al. Strong association between gallstones and cardiovascular disease. Am J Gastroenterol. 2005;100 (4):827-30. doi:10.1111/j.1572-0241.2005.41214.x.
12. Chavez-Tapia NC, Kinney-Novelo IM, Sifuentes-Renteria SE, et al. Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease. Ann Hepatol. 2012;11 (1):85-9.
13. Seddighi S, Ghidari ME, Sadeghi A, et al. Evaluation of the cardiovascular risk in patients with biliary stones: a descriptive cross-sectional study. Gastroenterol Hepatol Bed Bench. 2018;11 (Suppl 1): S14-S19.
14. Froutan Y, Alizadeh A, Mansour-Ghanaei F, et al. Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors. Int J Clin Exp Med. 2015;8 (7):11283-8.
15. Chen CY, Lu CL, Lee PC, et al. The risk factors for gallstone disease among senior citizens: an Oriental study. Hepatogastroenterology. 1999;46 (27):1607-12.
16. Alekseev SA, Bordakov VN. Surgical diseases: textbook in 2 parts. Part 2. — Minsk: the highest school, 2017. p. 33. (In Russ.) ISBN 978-985-06-2805-3.
17. Cho JY, Han HS, Yoon YS, et al. Risk factors for acute cholecystitis and a complicated clinical course in patients with symptomatic cholelithiasis. Arch Surg. 2010;145 (4):329-33. doi:10.1001/archsurg.2010.35.
18. Mendez-Sanchez N, Zamora-Valdes D, Flores-Rangel JA, et al. Gallstones are associated with carotid atherosclerosis. Liver Int. 2008;28:402-6. doi: 10.1111/j.1478-3231.2007.01632.x.
19. Chen LY, Qiao QH, Zhang SC, et al. Metabolic syndrome and gallstone disease. World J Gastroenterol.: WJG. 2012;18 (31):4215-20. doi:10.3748/wjg.v18.i31.4215.
20. Zamani F, Sohrabi M, Alipour A, et al. Prevalence and risk factors of cholelithiasis in Amol city, northern Iran: a population based study. Arch Iran Med. 2014;17 (11):750-4. doi:0141711/AIM.006.
21. Zhu L, Aili A, Zhang C, et al. Prevalence of and risk factors for gallstones in Uighur and Han Chinese. World J Gastroenterol. 2014;20 (40):14942-9. doi:10.3748/wjg.v20.i40.14942.
22. Xu Q, Tao LY, Wu Q, et al. Prevalences of and risk factors for biliary stones and gallbladder polyps in a large Chinese population. HPB (Oxford). 2012;14 (6):373-81. doi:10.1111/j.1477-2574.2012.00457.x.
23. Sachdeva S, Khan Z, Ansari MA, et al. Lifestyle and gallstone disease: scope for primary prevention. Indian J Community Med. 2011;36:263-7. doi:10.4103/0970-0218.91327.
24. Chen CH, Lin CL, Kao CH. Erectile Dysfunction in Men With Gallbladder Stone Disease: A Nationwide Population-Based Study. Am J Mens Health. 2019;13 (2):1557988319839589. doi:10.1177/1557988319839589.
25. Niemi M, Kervinen K, Rantala A, et al. The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects. Gut. 1999;44 (4):557-62.
26. Malta DC, Goncalves RPF, Machado IE, et al. Prevalence of arterial hypertension according to different diagnostic criteria, National Health Survey. Rev Bras Epidemiol. 2018;21 (suppl 1): e180021. doi:10.1590/1980-549720180021.supl.1.
27. Galson SW, Staton CA, Karia F, et а!. Epidemiology of hypertension in Northern Tanzania: a community-based mixed-methods study. BMJ Open. 2017;7 (11): e018829. doi:10.1136/bmjopen-2017-018829.
28. Kearney PM, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22 (1):11-9.
29. Grigorieva IN, Romanova TI. The Main risk factors and quality of life in patients with cholelithiasis. Experimental and clinical gastroenterology. 2011:4:21-5. (In Russ.)
30. Kim HS, Cho SK, Kim CS, et al. Big data and analysis of risk factors for gallbladder disease in the young generation of Korea. PLoS One. 2019;14 (2): e0211480. doi:10.1371/journal.pone.0211480.
31. Chen C, Yuan Z. Prevalence and risk factors for prehypertension and hypertension among adults in Central China from 2000-2011. Clin Exp Hypertens. 2018;40 (8):734-43.
32. Hu L, Huang X, You C, et ак Prevalence and Risk Factors of Prehypertension and Hypertension in Southern China. PLoS One. 2017;12 (1): e0170238. doi:10.1371/journal.pone.0170238.
33. Sun H, Tang H, Jiang S, et al. Gender and metabolic differences of gallstone diseases. World J Gastroenterol. 2009;15 (15):1886-91.
34. Grigorieva IN. Ursodeoxycholic acid in internal medicine. M.: Medical Practice-M, 2012. p. 47 (In Russ.) ISBN 978-5-98803-257-1.
35. Pak M, Lindseth G. Risk Factors for Cholelithiasis. Gastroenterol Nurs. 2016;39 (4):297-309. doi:10.1097/SGA.0000000000000235.
36. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology. 2009;136:376-86. doi :10.1053/j.gastro.2008.12.015.
37. Grigorieva IN, Nikitin YuP. Prevalence of cholelithiasis in different regions. Clinical medicine. 2007;9:27-30. (In Russ.)
38. Lazebnik LB, Kopaneva MI, Ezhova TB. the Need for medical care after surgery on the stomach and gall bladder (literature review and own data). Therapeutic archive. 2004;2:83-7. (In Russ.)
39. Grigorieva IN, Tikhonov AV, Shakhmatov SG, et al. Arterial hypertension and coronary heart disease as risk factors for gastrointestinal tract in women. Gastro-Bulletin. 2000;1-2:49-50. (In Russ.)
40. Malyutina SK, Simonova GI, Gafarov VV, et al. A Prospective study of the contribution of hypertension to the risk of cardiovascular events. Bulletin of the Siberian branch of the Russian Academy of Medical Sciences. 2003;23 (4):6-10. (In Russ.)
41. Grigorieva IN, Maksimov VN, Malyutina SK, et al. Gallstone disease associated with hypertension, but not with polymorphisms of angiotensin converting enzyme (epidemiological study). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2008;5 (Suppl. 32). р. 584. (In Russ.)
42. Kudelkina NA, Eliseenko AV. Cholelithiasis and functional disorders of the biliary tract in railway workers of Western Siberia (clinical and epidemiological study). Bulletin of the Siberian branch of the Russian Academy of Medical Sciences. 2009;3:95-104. (In Russ.)
43. Malyutina SK, Ryabikov AN, Shakhmatov SG, et al. Arterial hypertension and target organ damage: prognostic value of myocardial hypertrophy in the Siberian population. Bulletin of the Siberian branch of the Russian Academy of Medical Sciences. 2011;31 (5):53-8.(In Russ.)
44. Artyukhov IP, Grinshtein YI, Petrova MM, et al. Prevalence of arterial hypertension in the Krasnoyarsk Krai (Siberia, Russia). BMC Cardiovasc Disord. 2017;17 (1):138. doi:10.1186/s12872-017-0559-5.
45. Muhammad N, Rahimnajjad NA, Rahimnajjad MK, et al. Assessment of Characteristics of Patients with Cholilithiasis from economically deprived Rural Localities. BMC Res. Notes. 2012;5 (1):334.
46. Grigorieva IN, Logvinenko EV, Yamlikhanova AYu, et al. A look at cholelithiasis through the prism of metabolic syndrome. Bulletin of the Siberian branch of the Russian Academy of Medical Sciences. 2011;31 (5):72-8. (In Russ.)
47. Cojocaru C, Pandele GI. Metabolic profile of patients with cholesterol gallstone disease. Rev Med Chir Soc Med Nat Iasi. 2010;114 (3):677-82.
48. Yu KJ, Zhang JR, Li Y, et al. Gallstone disease is associated with arterial stiffness progression. Hypertens Res. 2017;40 (1):314. doi:10.1038/hr.2016.109.
49. Jiang ZY, Sheng X, Xu CY, et al. Gallbladder Gallstone Disease Is Associated with Newly Diagnosed Coronary Artery Atherosclerotic Disease: A Cross-Sectional Study. PLOS ONE. 2013;8: e75400. doi:10.1371/journal.pone.0075400.
50. Wei CY, Chung TC, Chen CH, еt аl. Gallstone disease and the risk of stroke: a nationwide population-based study. J Stroke Cerebrovasc Dis. 2014;23 (7):1813-20. doi:10.1016/j.jstrokecerebrovasdis.2014.04.024.
51. Kim JH, Ryoo JG, Lee JW, et al. Gallstones are Associated with Intima-Media Thickness of Common Carotid Arteries in Men. Korean J Fam Med. 2014;35 (3):136-42. doi:10.4082/kjfm.2014.35.3.136.
52. Wang JY, Lu FH, Sun ZJ, et al. Gallstone disease associated with increased risk of arterial stiffness in a Taiwanese population. J Hum Hypertens. 2017;31 (10):616-9. doi:101038/jhh.2017.43.
53. Medvedeva VN, Kuritsyna SI, Medvedev VN. Atherosclerosis of the abdominal aorta and carotid arteries and its correction with the content of lipids in the blood serum in cholelithiasis. Cardiology. 2003;37 (8):40-5. (In Russ.)
54. Serin HI, Yilmaz YK, Turan Y, et al. The association between gallstone disease and plaque in the abdominopelvic arteries. J Res Med Sci. 2017;27 (22): 11. doi: 10.4103/1735-1995.199087.
55. Vacca G, Battaglia A, Grossini E, et al. Reflex coronary vasoconstriction caused by gallbladder distension in anesthetized pigs. Circulation. 1996;94 (9):2201-9.
56. Molinari C, Grossini E, Mary DA, et al. Effect of distension of the gallbladder on plasma renin activity in anesthetized pigs. Circulation. 2000;101 (21):2539-45.
57. Lebedeva MS, Grigorieva IN, Maximov VN. Lipid profile, blood pressure, quality of life and clinical features of the course of cholelithiasis in combination with hypertension. Atherosclerosis. 2015;11 (3):56-62. (In Russ.)
58. Jeong YH, Kim KO, Lee HC, et al. Gallstone prevalence and risk factors in patients with ulcerative colitis in Korean population. Medicine (Baltimore). 2017;96 (31): e7653. doi:10.1097/MD.0000000000007653.
59. Bortnichak EA, Freeman DH, Ostfeld AM. The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts. Am J Epidemiology. 1985;121 (1):19-30.
60. Grigorieva IN, Ragino YuI, Romanova TI, et al. On the Association between coronary heart disease and cholelithiasis (epidemiological study) Atherosclerosis. 2019;1:25-9. (In Russ.)
Review
For citations:
Grigorieva I.N., Ragino Yu.I., Romanova T.I. Epidemiology and comorbidity of arterial hypertension and gallstone disease. Russian Journal of Cardiology. 2019;(6):143-148. (In Russ.) https://doi.org/10.15829/1560-4071-2019-6-143-148
Views:
1239
Email this article 